Carl A. Laskin

27 King's College Cir, M5S
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Increased Risk of Intrahepatic Cholestasis of Pregnancy in SLE Women Exposed to Azathioprine.

Increased Risk of Intrahepatic Cholestasis of Pregnancy in SLE Women Exposed to Azathioprine.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 11, 2025

Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review.

Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review.

Journal: EULAR rheumatology open

Published: April 16, 2025

An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.

An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.

Journal: Rheumatology (Oxford, England)

Published: January 28, 2025

A clinical care pathway for managing pregnancy in patients with inflammatory arthritis.

A clinical care pathway for managing pregnancy in patients with inflammatory arthritis.

Journal: Clinical rheumatology

Published: January 03, 2025

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial.

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial.

Journal: Annals of the rheumatic diseases

Published: December 12, 2024

Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study.

Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study.

Journal: The Lancet. Rheumatology

Published: August 25, 2024

Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review.

Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review.

Journal: The Journal of rheumatology

Published: July 16, 2024

Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.

Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.

Journal: The Journal of rheumatology

Published: May 14, 2024

Long-Term Outcomes of Children Born to Anti-Ro Antibody-Positive Mothers With and Without Rheumatic Disease.

Long-Term Outcomes of Children Born to Anti-Ro Antibody-Positive Mothers With and Without Rheumatic Disease.

Journal: Arthritis care & research

Published: April 26, 2024

Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes.

Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes.

Journal: Scientific reports

Published: November 14, 2023

2023 ACR/EULAR antiphospholipid syndrome classification criteria.

2023 ACR/EULAR antiphospholipid syndrome classification criteria.

Journal: Annals of the rheumatic diseases

Published: June 21, 2023

The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.

The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 07, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026